Currently submitted to: JMIR Human Factors
Date Submitted: Jan 14, 2026
Open Peer Review Period: Jan 21, 2026 - Mar 18, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The CAPABLE mHealth intervention: a qualitative study on patients’ perspectives.
ABSTRACT
Background:
The CAPABLE (Cancer Patients Better Life Experience) project developed an application for remote monitoring and management of treatment-related symptoms, as well as for delivering a set of supplementary nonpharmacological interventions, with the aim of improving patients’ quality of life. Clinical studies were conducted to evaluate the effectiveness of CAPABLE, yielding encouraging results. However, these studies did not explore individual patients’ perspectives.
Objective:
Following the evaluation of the CAPABLE intervention’s efficacy, this study aims at exploring end users’ overall experience with the telemonitoring system, identifying strengths and weaknesses in relation to users’ needs and expectations, in order to inform future developments.
Methods:
Toward the end of the clinical study, a focus group was conducted with a subset of enrolled patients. The discussion was led by a psycho-oncologist using a predefined framework of topic-related questions, which served as prompts to encourage open discussion. Patients freely shared their experiences, and a thematic analysis was performed on the collected statements.
Results:
The findings showed that the tool primarily served a dual function of support and reassurance. Patients reported psychological relief and a sense of security, driven by the perception of being closely monitored and supported by a multidisciplinary hospital team. CAPABLE was perceived as easy to use, effective, and useful. Nevertheless, several weaknesses also emerged. Suggestions for improvement focused on a closer alignment between CAPABLE functionalities and patients’ individual treatments and preferences, as well as concerns regarding application maintenance after the end of the project.
Conclusions:
The focus group provided valuable insights to inform the future development of telemonitoring applications for cancer patients.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.